Development of medications for alcohol use disorders: recent advances and ongoing challenges

Author： Litten Raye Z   Fertig Joanne   Mattson Margaret   Egli Mark  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.2, 2005-05, pp. : 323-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Alcohol Use Disorders

By Buonopane Alessandra   Petrakis Ismene  

Substance Use & Misuse, Vol. 40, Iss. 13-14, 2005-12 ,pp. : 2001-2020

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

By Verrico Christopher D   Haile Colin N   Newton Thomas F   Kosten Thomas R   De La Garza Richard  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1549-1568

Informa Healthcare

Access to resources Recommend Favorite

Physical Activity and Alcohol Use Disorders

By Lisha Nadra E.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 115-120

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Treatments for Alcohol and Cocaine Dependence: Focus on Topiramate and Other Modulators of GABA or Glutamate Function

By Johnson Bankole A.  

CNS Drugs, Vol. 19, Iss. 10, 2005-01 ,pp. : 873-896

Adis International

Access to resources Recommend Favorite

New glutamatergic target for alcohol and substance use disorder medications

By Vadasz Csaba   Saito Mariko  

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1429-1431

Springer Publishing Company

Access to resources Recommend Favorite